Pfizer and Saama expand deal to expedite clinical research
Pfizer has expanded its multi-year agreement with Saama, intensifying efforts to expedite clinical research.
View ArticleBMS signs $674m GenAI drug discovery deal with VantAI
The partnership will focus on designing molecular glues for unspecified therapeutic targets.
View Article1910 Genetics and Microsoft partner to enhance pharmaceutical R&D
1910 Genetics has entered an agreement with Microsoft, aiming to revitalise pharmaceutical research and development (R&D) productivity.
View ArticleSonrai Analytics and Candel to advance cancer treatment using AI
Sonrai Analytics has entered a partnership with Candel to expedite the development of viral immunotherapies for treating cancer.
View ArticleCTS Europe: The roadmap for generative AI in the pharma industry
AI remained one of the main talking points at CTS Europe, as the roadmap for generative AI was mapped out.
View ArticleTierra raises $11.4 in Series A round for predictive AI protein maker
The US company is part of a burgeoning artificial intelligence (AI) market in early-stage drug development.
View ArticleEli Lilly-backed Zephyr AI secures $111m for precision medicine tech
The funds will be used to expand Zephyr AI's headcount and enhance datasets.
View ArticleBeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Originally operating as a subsidiary under BeiGene, Pi Health has become an independent company with a Series A raise.
View ArticleMicrosoft and NVIDIA expand collaboration in healthcare innovation
Microsoft has announced plans to broaden its partnership with NVIDIA to leverage gen AI to enhance healthcare and life sciences innovation.
View ArticleNVIDIA doubles down on AI in healthcare with drug discovery deals
In addition to drug discovery deals, NVIDIA also announced partnerships with J&J MedTech and GE Healthcare for genAI in MedTech.
View ArticleCan pharma overcome generative AI’s bias problem?
While the use of generative AI to optimise the practitioner-to-patient relationship grows, ethical questions over bias thwart pharma’s reliance on the tech.
View ArticleQ&A: BARDA wants to back tech that can combat multiple infections, says director
The director of BARDA’s medical countermeasures programs, Robert Johnson, talks about what the agency is planning to invest in the future.
View ArticleBayer and Google Cloud to develop AI solutions for radiologists
Bayer has partnered with Google Cloud to develop AI-powered solutions for radiologists, creating scalable and compliant imaging software.
View ArticleTetraScience and Google Cloud link for AI-driven drug developments
TetraScience has formed a partnership with Google Cloud to expedite the development of drugs and other scientific advancements using AI.
View ArticleNIH team develops AI tool to predict cancer drug response
Researchers at the National Cancer Institute, a unit of the National Institutes of Health (NIH) in the US, have developed an AI tool that can predict drug responses in cancer treatment.
View Article
